# FDA Inspection 774247 - RX Medical - March 27, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/rx-medical/eea567c7-2baf-4ba3-abd6-6eda01fbd5a5
Source feed: FDA_Inspections

> FDA Inspection 774247 for RX Medical on March 27, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 774247
- Company Name: RX Medical
- Inspection Date: 2012-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1307128 - 2026-03-06](https://www.globalkeysolutions.net/records/fda_inspections/rx-medical/8690beea-2cec-4d50-adc2-eedd38185a7f)
- [FDA Inspection 1307128 - 2026-03-06](https://www.globalkeysolutions.net/records/fda_inspections/rx-medical/34d27418-819e-4da9-a0f2-2b5844e2c115)
- [FDA Inspection 1090672 - 2019-04-23](https://www.globalkeysolutions.net/records/fda_inspections/rx-medical/5ee6804b-ac64-45bf-a6a8-48bd17ab4008)
- [FDA Inspection 882481 - 2014-06-09](https://www.globalkeysolutions.net/records/fda_inspections/rx-medical/806e42a1-7689-4fff-88bb-8d9091e7e78b)

Company: https://www.globalkeysolutions.net/companies/rx-medical/b6270bdb-5a29-4409-9caa-2ef908346917

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d